Wall Street Access Asset Management »

Lenz Therapeutics shares owned by Wall Street Access Asset Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Wall Street Access Asset Management from 13F filings

Historical chart of Wall Street Access Asset Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Wall Street Access Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Wall Street Access Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $793k 17k 46.58
2025-06-30 $499k 17k 29.31
2025-03-31 $438k 17k 25.71
2024-12-31 $492k 17k 28.87
2024-09-30 $493k 21k 23.74

More positions owned by Wall Street Access Asset Management

iShares S&P 500 Index (IVV)
Berkshire Hathaway Inc Del Cl A Common Stock (BRK.A)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Inc Class C cs (GOOG)
Invesco S&p 500 Equal Weight Etf (RSP)
Amazon (AMZN)
Berkshire Hathaway (BRK.B)
Facebook Inc cl a (META)
American Balanced Fund Class F2 Mutual Fund (AMBFX)
T. Rowe Price Capital Appreciation Fund Class I Mutual Fund (TRAIX)
American Growth Fund Of America Class F2 Mutual Fund (GFFFX)
Dimensional Etf Trust (DFAS)
American Capital Income Builder Fund Class F2 Mutual Fund (CAIFX)
Vanguard Index Fds Vanguard Value Etf Common Stock (VTV)

View all positions for Wall Street Access Asset Management

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
BlackRock
Vanguard Group
UBS Group
Paradigm Biocapital Advisors
72 Investment Holdings
Tang Capital Management
Rtw Investments
First Light Asset Management
Adage Capital Partners GP
Franklin Resources
Morgan Stanley
Geode Capital Management

View all funds holding Lenz Therapeutics